| Tumor-associated fibroblasts promote HER2-targeted therapy resistance through FGFR2 activation P Fernández-Nogueira, M Mancino, G Fuster, A López-Plana, P Jauregui, ... Clinical Cancer Research 26 (6), 1432-1448, 2020 | 74 | 2020 |
| Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer P Fernández-Nogueira, A Noguera-Castells, G Fuster, L Recalde-Percaz, ... Cancer letters 424, 70-83, 2018 | 40 | 2018 |
| The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer A López‐Plana, P Fernández‐Nogueira, P Muñoz‐Guardiola, ... International Journal of Cancer 147 (4), 1163-1179, 2020 | 17 | 2020 |
| Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis A Zubeldia-Plazaola, L Recalde-Percaz, N Moragas, M Alcaraz, X Chen, ... Breast Cancer Research 20, 1-16, 2018 | 15 | 2018 |
| EACR-MRS conference on seed and soil: in vivo models of metastasis I Teles Alves, N Cohen, PG Ersan, R Eyre, I Godet, D Holovanchuk, ... Clinical & Experimental Metastasis 34, 449-456, 2017 | 1 | 2017 |
| The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma N Moragas, P Fernandez-Nogueira, L Recalde-Percaz, JL Inman, ... | | 2024 |
| Neuropilin-2 upregulation by stromal TGFβ1 induces lung disseminated tumour cells dormancy escape and promotes metastasis outgrowth L Recalde-Percaz, P Jauregui, A López-Plana, P Fernandéz-Nogueira, ... | | 2022 |
| Neuropilin 2 role in the regulation of disseminated tumour cells dormancy and metastasis in breast and head and neck cancer L Recalde-Percaz Universitat de Barcelona, 2021 | | 2021 |
| HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer P Fernandez-Nogueira, AN Castells, GF Orellana, LR Percaz, NM Garcia, ... Cancer Research 78 (13_Supplement), 5213-5213, 2018 | | 2018 |
| Understanding the microenvironment contribution to ductal carcinoma in situ transition to invasiveness in breast cancer N Moragas, L Recalde-Percaz, A Noguera-Castells, ... Cancer Research 78 (13_Supplement), 2138-2138, 2018 | | 2018 |
| Glucocorticoids mediate DCIS transition to IDC through myoepithelial cell apoptosis A Zubeldia-Plazaola, L Recalde-Percaz, N Moragas, M Mancino, ... Cancer Research 78 (13_Supplement), 80-80, 2018 | | 2018 |
| Role of syntaxin-1A, a synaptic-related protein, in HER2-enriched and luminal B breast cancer progression A Noguera-Castells, L Recalde-Percaz, N Moragas, ... Cancer Research 78 (13_Supplement), 5079-5079, 2018 | | 2018 |
| HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer P Fernandez-Nogueira, A Noguera-Castells, G Fuster, L Recalde, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 512-512, 2017 | | 2017 |
| STX1A signaling pathway characterization in different breast cancer subtypes A Noguera-Castells, L Recalde-Percaz, N Moragas, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 515-515, 2017 | | 2017 |
| NRP2-SEMA3s-PLXNs axis regulates the dormancy state of disseminated tumour cells and metastasis progression L Recalde-Percaz, A Noguera-Castells, N Moragas, M Mancino, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 518-518, 2017 | | 2017 |
| Substance P and its receptor NK1 regulates disseminated tumour cells biology and dormancy L Recalde-Percaz, P Jauregui, P Fernandez-Nogueira, R Alonso, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 497-497, 2017 | | 2017 |
